- Home
- NGVT vs OCUL Comparison
NGVT vs OCUL Comparison
Compare NGVT & OCUL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NGVT
- OCUL
- Stock Information
- Founded
- NGVT 1964
- OCUL 2006
- Country
- NGVT United States
- OCUL United States
- Employees
- NGVT N/A
- OCUL N/A
- Industry
- NGVT Major Chemicals
- OCUL Biotechnology: Pharmaceutical Preparations
- Sector
- NGVT Industrials
- OCUL Health Care
- Exchange
- NGVT Nasdaq
- OCUL Nasdaq
- Market Cap
- NGVT 1.7B
- OCUL 1.2B
- IPO Year
- NGVT N/A
- OCUL 2014
- Fundamental
- Price
- NGVT $44.90
- OCUL $7.85
- Analyst Decision
- NGVT Buy
- OCUL Strong Buy
- Analyst Count
- NGVT 5
- OCUL 8
- Target Price
- NGVT $51.00
- OCUL $16.50
- AVG Volume (30 Days)
- NGVT 207.9K
- OCUL 910.1K
- Earning Date
- NGVT 02-18-2025
- OCUL 03-10-2025
- Dividend Yield
- NGVT N/A
- OCUL N/A
- EPS Growth
- NGVT N/A
- OCUL N/A
- EPS
- NGVT N/A
- OCUL N/A
- Revenue
- NGVT $1,479,300,000.00
- OCUL $61,442,000.00
- Revenue This Year
- NGVT N/A
- OCUL $11.40
- Revenue Next Year
- NGVT $2.43
- OCUL $13.58
- P/E Ratio
- NGVT N/A
- OCUL N/A
- Revenue Growth
- NGVT N/A
- OCUL 6.45
- 52 Week Low
- NGVT $30.90
- OCUL $4.06
- 52 Week High
- NGVT $56.30
- OCUL $11.78
- Technical
- Relative Strength Index (RSI)
- NGVT 52.75
- OCUL 40.87
- Support Level
- NGVT $42.95
- OCUL $7.45
- Resistance Level
- NGVT $46.52
- OCUL $7.89
- Average True Range (ATR)
- NGVT 1.61
- OCUL 0.29
- MACD
- NGVT -0.03
- OCUL 0.02
- Stochastic Oscillator
- NGVT 52.49
- OCUL 51.97
About NGVT Ingevity Corporation
Ingevity Corp is a chemical manufacturer based in the United States. It conducts its operations through three segments, namely Performance Chemicals, Advanced Polymer Technologies, and Performance Materials. The bulk of its revenue is generated by the Performance Chemicals segment which deals with the manufacture and sale of specialty chemicals that find their use in a range of processes such as asphalt paving, oil exploration and production, agrochemicals, adhesives, lubricants, and publication inks. The Performance Materials segment, on the other hand, focuses on automotive carbon products used in automobiles. The Advanced Polymer Technologies segment produces caprolactone and caprolactone-based specialty polymers. The Company generates the majority of its revenue from North America.
About OCUL Ocular Therapeutix Inc.
Ocular Therapeutix Inc is a biotechnology company that specializes in therapies for diseases and conditions of the eye. The company uses its proprietary hydrogel platform technology to deliver therapeutic agents to the eye. Its pipeline consists of eye medication that aims to overcome the limitations of current eye-drop-based therapies for ophthalmic diseases and conditions. Its pipeline product includes Dextenza, OTX-TIC, OTX-TKI, and OTX-IVT.